logo

Health Care News

Share

BioRestorative Therapies Enrolls First Patient For Phase 2 Trial To Treat Chronic Lumbar Disc Disease

Royalty Pharma Buys Ex-U.S. Royalty Interest In Gavreto From Blueprint Medicines For Up To $340 Mln

Codiak BioSciences Announces Platform-validating Clinical Data From Phase 1 Trials Of ExoSTING And ExoIL-12

Sanofi: FDA Places Phase 3 Studies Of Tolebrutinib In Multiple Sclerosis And Myasthenia Gravis On Partial Clinical Hold

AstraZeneca Announces Positive High-level Results From Interim Analysis Of AEGEAN Phase III Trial